Introduction: Galectin-9 (Gal-9) induces adhesion and aggregation of certain cell types and inhibits the metastasis of tumor cells. T-cell immunoglobulin-and mucin domain-3-containing molecule 3 (TIM-3) plays a pivotal role in immune regulation. The aim of this study is to investigate Gal-9 and TIM-3 alterations in gastric cancer and their prognostic values.
Methods: Gal-9 and Tim-3 expression was evaluated using a tissue microarray immunohistochemistry method in 305 gastric cancers, of which 84 had paired adjacent normal samples. Cell lines SGC-7901, BGC-823, MGC-803, MKN45 and GES-1 were also stained. Correlations were analyzed between expression levels of Gal-9 and Tim-3 protein and tumor parameters or clinical outcomes.
Results: Gal-9 and Tim-3 stained positive on tumor cells in 86.2% (263/305), and 60.0% (183/305) patients with gastric cancer, respectively. Gal-9 expression was significantly higher in cancer than in normal mucosa (P<0.001). Reduced Gal-9 expression was associated with lymph-vascular invasion, lymph node metastasis, distant metastasis and worse TNM staging (P = 0.034, P = 0.009, P = 0.002 and P = 0.043, respectively). In contrast, Tim-3 expression was significantly lower in cancer than in control mucosa (P<0.001). Patients with lymph-vascular invasion had higher expression levels of Tim-3 (P<0.001). Moreover, multivariate analysis shows that both high Gal-9 expression and low Tim-3 expression were significantly associated with long overall survival (P = 0.002, P = 0.010, respectively); the combination of Gal-9 and Tim-3 expression was an independent prognostic predictor for patients with gastric cancer (RR: 0.43; 95%CI: 0.20-0.93). H.pylori infection status was not associated with Gal-9 and Tim-3 expression (P = 0.102, P = 0.565).
Conclusion: The results suggest that expression of Gal-9 and Tim-3 in tumor cells may be a potential, independent prognostic factor for patients with gastric cancer. Gal-9 and TIM-3 may play an important part in the gastric carcinogenesis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858245 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081799 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Immunomodulation by galectin-9: Distinct role in T cell populations, current therapeutic avenues and future potential.
Cell Immunol
January 2025
Princess Máxima Center for Pediatric Oncology, 3584CS Utrecht, the Netherlands; Division of Pediatrics, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands; Regenerative Medicine Center, University Medical Center Utrecht, 3584CT Utrecht, the Netherlands. Electronic address:
Galectins, glycan-binding proteins, have been identified as critical regulators of the immune system. Recently, Galectin-9 (Gal-9) has emerged as biomarker that correlates with disease severity in a range of inflammatory conditions. However, Gal-9 has highly different roles in the context of immunoregulation, with the potential to either stimulate or suppress the immune response.
View Article and Find Full Text PDFMoxibustion Regulates the Expression of T Cells in Rheumatoid Arthritis Through Tim-3/Gal-9 Signaling Pathway.
Rejuvenation Res
October 2024
Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
To observe the effects of moxibustion on T cells and T cell immunoglobulin and mucin-domain-containing molecule-3/galectin-9 (Tim-3/Gal-9) pathway in rats with rheumatoid arthritis (RA). To further explore the possible anti-inflammatory mechanism of moxibustion in the treatment of RA. Thirty Sprague Dawley rats were randomly divided into three groups, including a control group, an RA model group, and a moxibustion group.
View Article and Find Full Text PDFEffects of PACAP Deficiency on Immune Dysfunction and Peyer's Patch Integrity in Adult Mice.
Int J Mol Sci
October 2024
Department of Medical Microbiology and Immunology, Medical School, University of Pecs, 7624 Pecs, Hungary.
Article Synopsis
- PACAP is a neuropeptide known for its protective and anti-inflammatory effects, influencing both innate and adaptive immune responses, but there's limited research on its role in gut-associated lymphoid tissue.
- The study examined Peyer's patches in two groups of mice (wild-type and PACAP-deficient) at different ages, focusing on immune cell populations and checkpoint molecule expression.
- Findings revealed that aging affected T cell populations and checkpoint molecules in WT mice while PACAP KO mice showed altered immune responses, indicating that PACAP is critical for maintaining intestinal immune balance and may have implications for conditions like inflammatory bowel disease.
Features and prognostic significance of soluble TIM-3 and its ligands Gal-9 and CEACAM1 levels in the diagnostic bone marrow of adult acute myeloid leukemia patients.
J Leukoc Biol
December 2024
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, People's Republic of China.
Article Synopsis
- The study investigates the levels of soluble immune checkpoint molecules TIM-3, Gal-9, and CEACAM1 in the plasma of newly diagnosed adult patients with acute myeloid leukemia (AML) compared to healthy donors.
- Results show that AML patients had higher levels of soluble TIM-3, which was identified as a significant independent factor predicting poor relapse-free survival (RFS) and event-free survival (EFS).
- Additionally, elevated levels of soluble CEACAM1 and Gal-9 were associated with lower RFS, especially in patients undergoing allogeneic hematopoietic stem cell transplantation.
[Research progress on T-cell immunoglobulin mucin 3/galectin 9 (TIM-3/galectin-9) in tumour immunity].
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
August 2024
School of Basic Medical Sciences, Yunnan Key Laboratory for Biomedical Research and Development of Insects, Dali University, Dali 671000, China. *Corresponding author, E-mail:
With the ongoing advancement of immune checkpoint research, targeting tumors through immune checkpoint blockade has emerged as a crucial approach in cancer therapy. T cell immunoglobulin and mucin-domain containing protein 3 (TIM-3) functions as a negative immune checkpoint. It has been demonstrated that the interaction of TIM-3 with its ligand galectin-9 (Gal-9) can promote immune escape in a variety of cancers.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!